World's quality source for all-natural non-psychoactive phytocannabinoid medicine. At CBD Global we’ve taken a unique approach to making a difference in the fast growing industry of cannabis. We are not interested in the recreational aspects of the market. Instead, we focus our effort and resources on developing treatment delivery systems and high grade cannabinoid extracts that are entirely devoid of delta-9 tetrahydrocannabinol (THC). By removing the regulated schedule I controlled substance THC, we are able to provide patients of all demographics and geographies access to quality medicine without them having to worry about undesired psychoactive side effects, or legal risks. We have developed proprietary strains of cannabis that contain upwards of 90% CBD and less than 0.3% THC in concentrated form. This allows our farms the legal classification of hemp, and therefore the ability to sell our products globally – helping high need patients from having to uproot and relocate their families. Current Product Developments: (Refined Raw Extracts in the form of Concentrates and 100% Pure CBD Isolates, Vaporizers, Tinctures, Sublingual Tablets, Gel-Caps, Transdermal Patches, Transmucosal Sprays and Pulmonary Inhalers) Current Areas of Research: (DNA Fingerprinting, Genome Sequencing, Genotyping, Phenotype Expression Control, Cell Culturing, Gene Bank, Selected Breeding, Gene Silencing, Knockouts & Amplification, Advanced Extraction Techniques)